
<!-- saved from url=(0064)file:///C:/Users/kkazemi/Desktop/output/18492995/18492995_9.html -->
<html><head><meta http-equiv="Content-Type" content="text/html; charset=windows-1252"></head><body><table border="1">
<tbody><tr><td style="vertical-align:middle;">
<p><span class="font2">Particulars</span></p></td><td>
<p><span class="font2">3 months<br>ended<br>31.03.2018</span></p></td><td>
<p><span class="font2">3 months<br>ended<br>31.12.2017</span></p></td><td>
<p><span class="font2">3 months<br>ended<br>31.03.2017</span></p></td><td>
<p><span class="font2">Year ended<br>31.03.2018</span></p></td><td>
<p><span class="font2">Previous Year<br>ended<br>31.03.2017</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(Audited)<br>(Refer note 8)</span></p></td><td style="vertical-align:middle;">
<p><span class="font2">(Unaudited)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(Audited)<br>(Refer note 8)</span></p></td><td style="vertical-align:middle;">
<p><span class="font2">(Audited)</span></p></td><td style="vertical-align:middle;">
<p><span class="font2">(Audited)</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">Segment revenue</span></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">a. Small molecules</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">4,255</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">3,688</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">3,948</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">15,077</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">16,405</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">b. Biologies</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">2,408</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,898</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,633</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">7,702</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">7,018</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">c. Branded formulations</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,491</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,561</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,310</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">6,115</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">5,489</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">d. Research services</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">4,091</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">3,877</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">2,828</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">14,231</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">11,925</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">Total</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">12,245</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">11,024</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">9,719</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">43,125</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">40,837</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">Less: Inter-segment revenue</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(550)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(445)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(408)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(1,828)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(1,621)</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">Net sales/ Income from continuing operations</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">11,695</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">10,579</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">9,311</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">41,297</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">39,216</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">Segment results</span></p>
<p><span class="font2">Profit before interest and tax from each segment<br>a. Small molecules</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">852</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">820</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,066</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">2,843</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">4,142</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">b. Biologies </span><span class="font2" style="font-style:italic;">U</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">194</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(48)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">59</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(119)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,397</span></p></td></tr>
<tr><td>
<p><span class="font2">c. Branded formulations #</span></p></td><td>
<p><span class="font2">123</span></p></td><td>
<p><span class="font2">79</span></p></td><td>
<p><span class="font2">99</span></p></td><td>
<p><span class="font2">428</span></p></td><td>
<p><span class="font2">463</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">d. Research services</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,044</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">977</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">902</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">3,725</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">3,465</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">Total</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">2,213</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,828</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">2,126</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">6,877</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">9,467</span></p></td></tr>
<tr><td>
<p><span class="font2">Less: Interest</span></p></td><td>
<p><span class="font2">98</span></p></td><td>
<p><span class="font2">94</span></p></td><td style="vertical-align:middle;">
<p><span class="font2">22</span></p></td><td>
<p><span class="font2">388</span></p></td><td style="vertical-align:middle;">
<p><span class="font2">86</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">Other un-allocab!e expenditure / (income), net</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">181</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">237</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">517</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">389</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">884</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">Profit before tax and before exceptional items #</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,934</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,497</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,587</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">6,100</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">8,497</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">Segment assets</span></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">a. Small molecules</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">17,681</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">17,759</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">16,116</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">17,681</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">16,116</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">b. Biologies</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">36,038</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">34,434</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">34,111</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">36,038</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">34,111</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">c. Branded formulations</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">2,927</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">3,039</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">2,386</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">2,927</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">2,386</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">d. Research services</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">31,890</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">28,588</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">27,738</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">31,890</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">27,738</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font2">88,536</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">83,820</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">80,351</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">88,536</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">80,351</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">e. Unallocable</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">11,361</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">12,447</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">13,591</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">11,361</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">13,591</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">Total segment assets</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">99,897</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">96,267</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">93,942</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">99,897</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">93,942</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">Segment liabilities</span></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">a. Small molecules</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">4,320</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">4,722</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">3,548</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">4,320</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">3,548</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">b. Biologies</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">7,704</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">7,037</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">8,251</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">7,704</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">8,251</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">c. Branded formulations</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,872</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">2,135</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,650</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,872</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">1,650</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">d. Research services</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">14,686</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">11,899</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">13,607</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">14,686</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">13,607</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font2">28,582</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">25,793</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">27,056</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">28,582</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">27,056</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">e. Unallocable</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">14,830</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">15,325</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">14,748</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">14,830</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">14,748</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">Total segment liabilities</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">43,412</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">41,118</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">41,804</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">43,412</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">41,804</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">Capital employed</span></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td></tr>
<tr><td>
<p><span class="font2">a. Small molecules</span></p></td><td>
<p><span class="font2">13,361</span></p></td><td>
<p><span class="font2">13,037</span></p></td><td>
<p><span class="font2">12,568</span></p></td><td>
<p><span class="font2">13,361</span></p></td><td>
<p><span class="font2">12,568</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">b. Biologies</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">28,334</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">27,397</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">25,860</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">28,334</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">25,860</span></p></td></tr>
<tr><td>
<p><span class="font2">c. Branded formulations</span></p></td><td>
<p><span class="font2">1,055</span></p></td><td>
<p><span class="font2">904</span></p></td><td>
<p><span class="font2">736</span></p></td><td>
<p><span class="font2">1,055</span></p></td><td>
<p><span class="font2">736</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">d. Research services</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">17,204</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">16,689</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">14,131</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">17,204</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">14,131</span></p></td></tr>
<tr><td>
<p></p></td><td style="vertical-align:bottom;">
<p><span class="font2">59,954</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">58,027</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">53,295</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">59,954</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">53,295</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">e. Unallocable</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(3,469)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(2,878)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(1,157)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(3,469)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">(1,157)</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2">Total capital employed</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">56,485</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">55,149</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">52,138</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">56,485</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2">52,138</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font2"># includes share of profit/loss of joint venture and<br>associates</span></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td><td>
<p></p></td></tr>
</tbody></table></body></html>